JCR Pharmaceuticals (4552.T) Earnings Analysis
JCR Pharmaceuticals (4552.T) next reports earnings on 2026-07-30, consensus EPS -11.27 JPY. Last quarter (2026-01-28) it beat with EPS 0.27 JPY vs -1.07199 JPY est (+125.2%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E 29.16.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4552.T next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | -11.27 JPY |
| Revenue estimate | 9.97B |
4552.T earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-01-28 | 0.27 JPY | -1.07199 JPY | +125.2% | Beat |
| 2025-10-30 | 18.5 JPY | 20.39 JPY | -9.3% | Miss |
| 2025-07-30 | -4.48111 JPY | 4.36 JPY | -202.8% | Miss |
| 2025-01-31 | 0.9 JPY | 9.49 JPY | -90.5% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
4552.T valuation and analyst view
| Trailing P/E | 29.16 |
|---|---|
| Trailing EPS | 17.861 JPY |
| Price / book | 1.35 |
| Dividend yield | 3.84% |
| Market cap | 63.68B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is JCR Pharmaceuticals (4552.T)'s next earnings date?
JCR Pharmaceuticals is next scheduled to report on 2026-07-30, with a consensus EPS estimate of -11.27 JPY and revenue estimate of 9.97B.
Did 4552.T beat earnings last quarter?
In its 2026-01-28 report, 4552.T posted EPS of 0.27 JPY versus a -1.07199 JPY estimate — a beat of 125.2%.
What is 4552.T's earnings track record?
Over the last 4 reported quarters with consensus data, 4552.T beat estimates 1 times (25%).
What is 4552.T's current P/E ratio and EPS?
4552.T trades at a trailing P/E of 29.16 on trailing EPS of 17.86080213772244 JPY.
What do analysts rate 4552.T?
4552.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.